News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Protect Pharmaceutical Corp. (PRTT) Completes Merger with KARINCA Logistics
Thursday, August 29, 2024Protect Pharmaceutical Corp announces it completed the necessary documentation to finalize the merger with KARINCA Logistics wwwkarincalogisticscom PRTTs Management believes that the KARINCA Logistics merger should add substantial
Addex and Indivior Select Clinical Candidates from GABAB Positive Allosteric Modulator Research Collaboration
Wednesday, August 28, 2024Addex Therapeutics a clinicalstage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders and Indivior PLC today announced the selection of clinical candidates from their G...
OKYO Pharma Granted U.S. Patent Covering OK-101’s Potential for Treating Symptoms of Dry Eye Disease
Wednesday, August 28, 2024OKYO Pharma Limited a clinicalstage biopharmaceutical company developing innovative ocular therapies for the treatment of inflammatory dry eye disease DED a multibilliondollar market and anterior ocular segment diseases including neuropathic corneal...
Currax Pharmaceuticals: CONTRAVE®/MYSIMBA® Demonstrates Positive Cardiovascular Safety in a Large, Real-World Evidence Study
Tuesday, August 27, 2024Currax Pharmaceuticals LLC announced the results of a Cardiovascular Health Outcomes Analysis HOA The results showed there is no evidence of excess cardiovascular risk and no statistically significant difference in major adverse cardiovascular event...
Biopharmaceutical Excipients Focused Market Insights 2024-2029: Demand for Novel Excipients in Advancing Biopharmaceutical Development - ResearchAndMarkets.com
Saturday, August 24, 2024The Biopharmaceutical Excipients Market Focused Insights report has been added to ResearchAndMarketscoms offering The Biopharmaceutical Excipients Market was valued at USD billion in and is expected to reach USD billion by rising at a CAGR of
Rafael Holdings and Cyclo Therapeutics Sign Definitive Merger Agreement
Friday, August 23, 2024Rafael Holdings Inc and Cyclo Therapeutics Inc announced that they have entered into a definitive merger agreement to combine the two companies to focus on the development of Trappsol Cyclo for the treatment of NiemannPick Disease Type C
PharmAla Introduces MDMA Clinical Trial Tool for Researchers
Friday, August 23, 2024PharmAla Biotech Holdings Inc a biotechnology company specializing in the research development and manufacturing of LaNeo MDMA and novel derivatives within the MDXX class is excited to announce the release of a new tool designed to assist researchers
Crown Bioscience Collaborates with CTI to Enhance Consulting Services in Oncology Drug Development
Thursday, August 22, 2024Crown Bioscience a global contract research organization CRO and a JSR Life Sciences company today announced a strategic partnership with Clinical Trial Consulting Services CTI a renowned global fullspectrum research service provider to bolster onco...
Monopar Receives Clearance to Proceed with Phase 1 Therapeutic Trial of Novel Radiopharmaceutical in Advanced Cancers
Thursday, August 22, 2024Monopar Therapeutics Inc a clinicalstage radiopharma company focused on developing innovative treatments for cancer patients today announced it has received Human Research Ethics Committee HREC clearance in Australia
Cumulus Oncology and leadXpro Reach Key Milestone in GPR68 Drug Discovery Project
Wednesday, August 21, 2024Cumulus Oncology Europes first biotech company dedicated to oncology innovation has announced significant progress in its GPR drug discovery project in collaboration with leadXpro LXP This achievement has allowed Cumulus to license the small molecule...
